comparemela.com

Page 7 - Company Or Innocan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Innocan Pharma Corporation: Innocan Pharma Announces 5000 Units Sale and Expansion to Lithuania, Latvia & Estonia Markets

HERZLIYA, Israel and CALGARY, AB, May 1, 2023 /PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce the entering

Tel avivIris bincovichInnocan pharmaVidmantas lozysEva reuterCompany or innocanPrnewswire innocan pharma corporationInnocan pharma corporationBi sky global ltdMedexy healthPharma corporationDistribution agreementEastern europeanGlobal sales analysis reportSales channels pharmaciesOnline skin platforms

Innocan Pharma Corporation: Innocan Pharma Reports Annual 2022 Results with USD 2 6M in Revenue

HERZLIYA, Israel and CALGARY, Alberta, April 18, 2023 /PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") a pharmaceutical technology

Tel avivIris bincovichRoni kamhiInnocan pharmaEva reuterBi sky global ltdPrnewswire innocan pharma corporationInnocan pharma corporationInnocan brandzon coCompany or innocanPharma corporationLiposomes cannabinoidsExosome cannabinoids synergismPremium dermalCentral nervous systemConsumer wellness

Innocan Pharma Reports Annual 2022 Results with USD 2 6M in Revenue

/PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on.

Tel avivRoni kamhiEva reuterInnocan pharmaIris bincovichInnocan pharma corporationPrnewswire innocan pharma corporationBi sky global ltdCompany or innocanPharma corporationSky globalLiposomes cannabinoidsExosome cannabinoids synergismPremium dermalCentral nervous systemConsumer wellness

Innocan Reports Novel Cannabinoid Delivery Platform Patent Application

/PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a leading pharmaceutical technology company.

Tel avivKeren primor cohenEva reuterIris bincovichRamot tel aviv universityInnocan pharma corporationCompany or innocanBi sky global ltdRamot at tel aviv university ltdWorld intellectual property organizationRamot at tel aviv universityPrnewswire innocan pharma corporationPharma corporationTel aviv universityWorld intellectual propertyCentral nervous system

Innocan Pharma Corporation: Innocan Pharma Announces Launch of CBD Veterinary Commercialization Team

Herzliya, Israel and Calgary, Alberta (Newsfile Corp. - March 17, 2023) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company

Tel avivDennis riedlIris bincovichEva reuterBi sky global ltdCompany or innocanAlberta newsfile corpInnocan pharma corporationPharma corporationCentral nervous systemConsumer wellnessJoint venture

vimarsana © 2020. All Rights Reserved.